Full-Time

Cardiology Business Development Representative-Atlanta

Posted on 8/27/2024

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Healthcare

Compensation Overview

$125kAnnually

+ Total target compensation of $200,000 + Stock options

Senior, Expert

Atlanta, GA, USA

Expect approximately 20-25% travel from a home office.

Category
Business Development
Business & Strategy
Required Skills
Sales
Marketing
Requirements
  • Proven sales skills and track-record of sales achievement
  • 4-year degree with 5+ years of related sales or clinical experience or 2-year degree with 7+ years related sales or clinical experience
  • Degree in Science, Medical, Business, Marketing or Technical field is preferred
  • Prior experience in medical device, cardiology pharmaceuticals, cardiology radio-pharmaceuticals, hospital, or medical software is highly desired
  • Experience with introducing new cardiovascular technologies into hospitals is highly desired
Responsibilities
  • Will work with key strategic HeartFlow accounts to drive growth and adoption of a cCTA and FFRct clinical pathway. In these accounts, the BDR will develop and execute business development plans working closely with the account’s key stakeholders
  • Facilitate cross-functional collaboration throughout the organization. Tools for program development could include key deployment of HeartFlow internal leadership and physician mentors, organizing and staffing of dinner programs, VIP Visits, organizing HeartFlow CT Pathway road-shows, referring physician office meetings, etc. This role will work closely with the other HeartFlow team members to include respective DSM, Marketing, Market Access, CT Apps, Product Development and Clinical
  • Increase HeartFlow usage within the designated key strategic HeartFlow account by: 1) Maintaining and building relationships with referring physicians and other key clinical stakeholders 2) Educating customers on HeartFlow’s value proposition by giving presentations / having discussions with referring MDs 3) Promoting / championing HeartFlow and building advocacy
  • Production/Success/Achievement of the Business Development Representative will be evaluated and based on performance in active/targeted accounts(metrics): 1) Meet / exceed quota for the strategic HeartFlow account (within existing customer locations) 2) cCTA growth (conversion of non-invasive tests) and FFRct penetration / case growth over baseline (% and $) in assigned accounts.

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main products include the HeartFlow Analysis, which encompasses various analyses like FFRCT, RoadMap, Plaque, and HeartFlow Planner. These products have received FDA clearance and are available in the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a safer and more efficient diagnostic method for cardiovascular care. The company's goal is to enhance the quality of heart disease treatment through advanced visualization technology.

Company Stage

Series F

Total Funding

$858.5M

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • HeartFlow closed a $215 million Series F funding round in April 2023.
  • The global non-invasive cardiac imaging market is projected to grow significantly.
  • HeartFlow's technology aligns with the trend towards value-based care in healthcare.

What critics are saying

  • Emerging AI-driven competitors could threaten HeartFlow's market share.
  • Algorithmic bias in AI models could lead to inaccurate diagnoses.
  • Integration into healthcare systems may face resistance due to complexity and cost.

What makes HeartFlow unique

  • HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
  • HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
  • HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Stock Options

401(k) Company Match

INACTIVE